Axicabtagene ciloleucel, known by the brand name Yescarta, has been accepted for treating adults with two types of blood cancer.

By Ayako Wakatsuki Pedersen, Ph.D., Senior Vice President of Translational Research at IO Biotech | Making the tumor microenvironment hostile to cancer cells and immune-suppressive cells may transform ...

Dizal has submitted sunvozertinib’s new drug application (NDA) to the US Food and Drug Administration (FDA) aiming to secure approval for treating locally advanced or metastatic non-small cell lung ...

It comes as new analysis by Asthma and Lung UK found lung diseases were responsible for one in eight emergency hospital ...

Around the same time, the cancer in his lung had spread to the lymph node within his thorax. He had to go for chemotherapy ...

Treatment options for prostate cancer vary depending on the ... often dismissing their symptoms or feeling embarrassed to ...

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

Even current smokers who quit after being diagnosed with cancer are better able to heal and respond to treatment, reducing the chance of death from some cancers by up to 40 percent. Think you need a ...

NEW YORK (WABC) -- A mother from Queens is opening up about motherhood amid her battle against an aggressive form of cancer.

Additionally, positive findings from trials like ADRIATIC (NCT03703297) and IMforte (NCT05091567) are further shaping ...

After cancer treatment, I wanted to go right back to living my life normally, but a fellow CURE blogger’s post reminded me ...